The Global Cardiac Biomarkers Market is driven by the rising prevalence of cardiovascular diseases, demanding rapid, accurate diagnostics. Opportunities lie in technological advancements in biomarker ...

A recent publication in JACC: Advances shows a previously unrecognized link between cardiac disease and cancer. The research focused on cardiac biomarkers, which are biological molecules that can ...

Clinical measures and biomarkers during pregnancy, including hs-cTnI and sFlt-1, can help identify women at higher risk of developing cardiovascular disease later in life.

Please provide your email address to receive an email when new articles are posted on . Elevated levels of cardiac biomarkers were indicative of future cancer risk. The association between biomarkers ...

Incorporating cardiac biomarkers into heart failure (HF) assessment may better pinpoint patients who otherwise would have been missed by older disease definitions, data from the ARIC study suggest.

The BNP and NTproBNP market growth is driven by rising cardiovascular diseases and an aging population. Opportunities lie in ...

Compassion fatigue in surgical oncologists: A scoping review. This is an ASCO Meeting Abstract from the 2024 ASCO Quality Care Symposium. This abstract does not include a full text component.

Clinical measures and blood biomarkers collected during pregnancy could offer early insight into a woman’s long-term cardiovascular health.

Patients hospitalized for influenza are just as likely as those admitted for COVID-19 to have signs of myocardial involvement, according to a study out Ontario, Canada. Though patients with COVID-19 ...

Nearly 1 in 5 US adults with type 2 diabetes but without symptoms of cardiovascular disease (CVD) have a clinically meaningful elevation of a marker of cardiac damage — namely, high sensitivity ...